|Place of Origin:||China|
|Certification:||GMP, ISO 9001, USP|
|Model Number:||CAS No: 315-37-7|
|Minimum Order Quantity:||Free samples Available|
|Packaging Details:||as your required|
|Delivery Time:||3-7 working days|
|Payment Terms:||Western Union, MoneyGram, T/T.Bitcoin|
|Supply Ability:||500 kg / month|
|Other Name:||Test E||MW:||400.594|
|Assay:||97.0%-102.0%||Appearance:||White Or Almost White Powder.|
|MP:||34-39 Centigrade||Shipment:||FedEx, TNT, EMS, DHL.UPS,EUB|
testosterone raw powder,
cutting cycle steroids
Indications and Usage for Testosterone Enanthate
Testosterone Enanthate Injection, USP is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone.
Primary hypogonadism (congenital or acquired) – Testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy.
Hypogonadotropic hypogonadism (congenital or acquired) – Gonadotropin or luteinizing hormone‑releasing hormone (LHRH) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. (Appropriate adrenal cortical and thyroid hormone replacement therapy are still necessary, however, and are actually of primary importance.)
If the above conditions occur prior to puberty, androgen replacement therapy will be needed during the adolescent years for development of secondary sexual characteristics. Prolonged androgen treatment will be required to maintain sexual characteristics in these and other males who develop testosterone deficiency after puberty.
Safety and efficacy of Testosterone Enanthate Injection, USP in men with “age-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established.
Metastatic mammary cancer – Testosterone Enanthate Injection, USP may be used secondarily in women with advancing inoperable metastatic (skeletal) mammary cancer who are one to five years postmenopausal. Primary goals of therapy in these women include ablation of the ovaries.
Other methods of counteracting estrogen activity are adrenalectomy, hypophysectomy, and/or antiestrogen therapy. This treatment has also been used in premenopausal women with breast cancer who have benefited from oophorectomy and are considered to have a hormone-responsive tumor. Judgment concerning androgen therapy should be made by an oncologist with expertise in this field.
Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant. When administered to pregnant women, androgens cause virilization of the external genitalia of the female fetus. This virilization includes clitoromegaly, abnormal vaginal development, and fusion of genital folds to form a scrotal-like structure.
The degree of masculinization is related to the amount of drug given and the age of the fetus and is most likely to occur in the female fetus when the drugs are given in the first trimester. If the patient becomes pregnant while taking androgens, she should be apprised of the potential hazard to the fetus.
This preparation is also contraindicated in patients with a history of hypersensitivity to any of its components.
|Product name||Testosterone Enanthate|
|Other name||Primoteston Depot|
|CAS register number||315-37-7|
|Usage||in building muscle, burning fat and gaining strength|
|Minimum order quantity||10g|
|Package:||Exquisite and can according to customers' requirement|
|Shipping leading time||Within 24 hours after receiving the payment|
|Payment options||Western Union, MoneyGram, bank transfer|
|Shipping||1)Express delivery with DHL, EMS, Fedex, TNT, UPS(within 5-7days after payment)|
Any needs, please contact me